Report Description Table of Contents Endovascular Aneurysm Repair Market Growth 2030, Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted, Go-to-Market (GTM) Strategy, Government Regulations, Reimbursements, FDA Approvals, Supply Chain Analysis, Startup Ecosystem & Product Rating, etc The global endovascular aneurysm repair market will witness a robust CAGR of 5.8%, valued at $3.03 billion in 2021, expected to appreciate and reach $5.03 billion by 2030, confirms Strategic Market Research. Endovascular aneurysm repair is a minimally invasive technique for treating abdominal aortic aneurysms. Aorta is one of the largest artery in the body, carrying blood from the heart to the rest of the body. EVAR employs small punctures & sophisticated equipment to mend bulges in the blood vessels (aneurysms) found in the abdomen. Endovascular aneurysm repair is designed to prevent the abdominal aortic aneurysm from rupturing, which is a potentially a fatal situation. An aneurysm occurs when the pressure of the blood flow forces a weak area in the blood vessel wall (the aorta) causing it to balloon outward. This might cause a burst, cutting off the blood supply to organs. By relieving pressure on the aneurysm and relining it with a new tube, EVAR reduces the risk of a rupture. A metal mesh frame supports the fabric tube, often known as a stent graft. Due to the rising prevalence of the condition, the abdominal aortic aneurysm held a significant position, with a revenue share of over 70.0% in 2021. The lower abdomen is where AAA is most frequently found, and the majority of instances are either right under the kidney or in pararenal region of the lower abdomen. There are substantially more repairs for pararenal and subrenal aneurysms than Thoracic aortic aneurysms (TAA). Around 2.5% of the people over the age of 65 have AAA, according to a Circulation article. TAA, however, only happens 4.5% to 5.9% of the time per 100,000 persons per year. North America's EVAR market maintained a commanding share of 33% in 2021. It is caused by the high occurrence of aneurysms and the elements that favour their growth. The region also concentrates on creating and innovating reliable medical infrastructure items, which supports the market's expansion even more. In the USA, about 116 million adults, or close to half of all adults, experience hypertension, which is a major cause of aneurysms. According to the Center for Disease Control & prevention, there are 17,220 instances of aneurysms reported annually in North America. In addition, Asia-Pacific is expected to provide profitable growth prospects for marketers. It is due to recent developments in medical research and the governing objectives of nations like Korea and Japan to quickly improve and launch new EVAR-related products. EVAR is a procedure for the treatment of an aneurysm of the aorta. This procedure is mainly conducted in the surgery of abdominal and thoracic aortic aneurysm. An aneurysm refers to a balloon-like bulge of an artery wall, and as it grows slowly, pressure is created on the nearby structures, which may further cause a wound or rupture. In the Endovascular Aneurysm Repair treatment procedure, a stent is placed in the area of the affected aorta and ductus arteriosus, where it acts as an alternative channel for blood flow. This stent graft helps in eliminating the blood flow pressure in the aneurysm sac and reduces the risk of rupturing the aneurysm walls. The EVAR method, which uses an endovascular stent graft, is a good substitute to open surgery since it does not include any surgical incisions and is non-invasive. Moreover, EVAR procedures are currently in high demand because of their minimally invasive nature and speedy recovery. In the United States, EVAR is used in about 70% of the 70,000 abdominal aortic repair procedures. The repair of an aneurysm depends on several factors like the shape and the location of the aneurysm. Through small incisions in the groin, a fabric tube backed up by metal wire stents known as a stent graft is pushed into the aneurysm in the whole procedure of EVAR. This aortic stent-graft used in the aortic part of the body plays a vital role in strengthening the weak spot in the aorta. Then, with the help of anaesthesia and surgical suture, revascularization is done within the process of the treatment. This revascularization can help the ischemia (insufficient blood supply to any part or organ of the body, especially the heart muscles) to act normally. Before the treatment process, Angiography (a type of X-ray used to check the conditions and visualize the inside of the wounded blood vessels) is executed. Moreover, if any fistula is formed, it can be easily noticed during the process of Angiography. Impact of Covid 19 Due to the worldwide pandemic, medical device makers are concentrating their efforts on producing crucial medical products such as ventilators and diagnostics. However, the supply chain process has been highly disrupted due to the preventive actions implemented by the governments in various countries, resulting in a shortfall of medical equipment and devices. Hence due to the COVID-19 pandemic, the market is likely to have an adverse impact due to deferral of non-urgent medical processes and a reduction in diagnosis. Market Dynamics The introduction of new grafts for complex aneurysms, such as fenestrated aortic stent-grafts, has expanded the medical decisions and treatment for aortic aneurysms, which will further help to expand the market. Furthermore, with the recent advancements in fenestrated stent-graft technology, endovascular approaches are becoming the best solutions to treat patients having complex anatomies. Moreover, the increase in the aortic aneurysm patient population is predicted to benefit the overall growth of the endovascular aneurysm repair market. The improvement of available EVAR devices is crucial for the advancement of patient care in vascular surgery. Also, the growing number of government screening programs for the elderly population to detect aortic aneurysms has provided immense growth opportunities for the market. Market Drivers The global market is likely to be driven by the growing elderly population in industrialized countries and an increase in tobacco smokers. The endovascular surgical procedures will also be benefited from the currently occurring technological developments, thus boosting the market growth to a great extent. The increased acceptance of endovascular stent-grafts and the introduction of next-generation stent-grafts, such as Excluder (W. L. Gore & Associates, Inc.), Zenith (Cook Medical Inc.), and many others, are driving the global endovascular aneurysm repair market. Furthermore, increased awareness in emerging nations regarding the offering of a broad range of aortic aneurysm devices is sure to attract the patient base, resulting in lucrative growth possibilities for the EVAR market. Restraint In the last two decades, the endovascular aneurysm repair (EVAR) procedure has gained immense popularity globally. However, the evolution of patient safety in surgical intervention relies on the current progression of the EVAR equipment. Many of the problems associated with the grafts can necessitate the patient to do open repair surgery or even result in rupture of the aneurysm. Moreover, the most commonly occurring complication in the overall EVAR procedures is the Endoleaks. It represents the consistent blood flow infusing the residual aneurysm sac, thus indicating failure of the whole process. Also, the market's expansion is hampered by the high cost of EVAR treatments and the dangers connected with them. Opportunity EVAR using contemporary devices is a safe, effective, and durable method to prevent aortic rupture procedures, and so it will become highly effective in the future. Hence, it will boost the entire market to grow in the upcoming years. Moreover, Abdominal Aortic Aneurysms (AAAs) outnumbered Thoracic Aortic Aneurysm Repair (TAA) threefold, especially in men aged 65 and up. The demand for improved stent-graft systems treating AAA has risen as a result. On the other hand, TAA treatments are uncommon due to a lack of multiple therapeutic devices and their difficulty. This offers manufacturers a lucrative opportunity to create advanced solutions for repairing thoracic endovascular aneurysms (TEVAR). Endovascular Aneurysm Repair Market Analysis Of Different Segments Covered in the Report Market Breakup by Types Thoracic Aortic Aneurysm Abdominal Aortic Aneurysm Cerebral Aortic Aneurysm Others Market Breakup by End-User Hospitals Clinics Ambulatory Surgical Centres Others Regional Coverage Analysis North America U.S. Canada Mexico Rest of North America Europe Germany France UK Italy Spain Rest of Europe Asia-Pacific Japan China India Australia South Korea Taiwan Rest of Asia-Pacific LAMIA Brazil Turkey Saudi Arabia Republic of South Africa Rest of LAMEA Based on Types, the ‘Abdominal Aortic Aneurysm (AAA)’ segment holds the largest market share and is assured of maintaining a leading position over the forecasted period. Furthermore, during the projected timeframe, the thoracic aortic aneurysm (TAA) segment is predicted to grow at the fastest rate of 8.8% due to an increase in the development of advanced devices for the treatment of thoracic aneurysms around the world. Based on End-User, the ‘Hospitals’ segment detains the highest market share. This is because most of the patients prefer to do treatments in the hospital premises, and so it will maintain a leading position throughout the forecasted period. By regional analysis, the ‘North America’ segment possesses the largest market share. Due to the rise of modern innovative medical technologies in this region, it will maintain a leading position in the upcoming future. In 2020, Asia-Pacific and Latin America together accounted for about 18% of the total market. It is due to the increased endovascular aneurysm repairs, particularly in China, India, and other emerging countries. The expansion of the market in Asia-Pacific is mostly due to an increase in the geriatric population. Endovascular Aneurysm Repair Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 3.03 Billion The revenue forecast in 2030 USD 5.03 Billion Growth rate CAGR of approximately 5.8% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation Market Breakup by Types, Market Breakup by End-User, Based on End-User, Based on Regions. Market Breakup by Types Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Cerebral Aortic Aneurysm, Others. Market Breakup by End-User Hospitals, Clinics, Ambulatory Surgical Centres, Others. Market Breakup by Geography North America, Europe, Asia Pacific, LAMIA. Country Scope U.S, Canada, France, Germany, U.K, China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Boston Scientific Corp, Smith and Nephew plc, El.En. Spa, ARC Laser GmbH, IRIDEX Corp, Lumenis Ltd, Olympus Corp, Limmer Laser GmbH, Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Sunny Optoelectronic Technology Co. Ltd. Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Endovascular Aneurysm Repair Market Competitive Landscape Analysis Numerous prominent firms have made acquisitions and developed new products to meet EVAR processes and equipment demand. Also, various EVAR products are predicted to grow at the highest CAGR of 6.9% throughout the projected timeframe, owing to rising demand for advanced techniques, an increase in aneurysm occurrence, and a quick increase in the worldwide elderly population. This opens up new opportunities for producers in the EVAR space. As a result, leading companies are nurturing their next-generation EVAR products, developing, innovating, and creating momentum to propel the market forward. Medtronic plc Cook Group Incorporated W. L. Gore & Associates Inc. Bolton Medical Inc. Gamida Cell Ltd. JOTEC GmbH Getinge AB (Maquet) Shanghai MicroPort Medical (Group) Co. Ltd. Terumo Corporation Endologix Inc. Lombard Medical Limited Cardinal Health Recent Developments The GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System is a next-generation endovascular aneurysm repair (EVAR) device designed to treat abdominal aortic aneurysms (AAA) in individuals with difficult anatomy. The market had also established an efficient method for approving the Zenith Dissection Endovascular System. This device comprises an intermediate stent-graft element and a distal bare stent component, giving doctors a less invasive option to open surgery for treating Type B descending thoracic aorta dissections. Frequently Asked Question About This Report How big will the Endovascular Aneurysm Repair Market be? The Endovascular Aneurysm Repair Market is expected to reach $3,604 million by the year 2023 What is the growth rate of the Endovascular Aneurysm Repair Market? The growth rate of the Endovascular Aneurysm Repair Market is 6.2% Who are the key players in global market? The key players in the market are Medtronic plc, Cook Group Incorporated, W. L. Gore & Associates Inc., Bolton Medical Inc., Gamida Cell Ltd., JOTEC GmbH, Getinge AB (Maquet), Shanghai MicroPort Medical (Group) Co. Ltd., Terumo Corporation, Endologix Inc., Lombard Medical Limited, Cardinal Health. Which region possesses the highest growth rate in global market? The Asia Pacific region has the highest growth rate in the market Which region holds the largest share in global market? The North American region has the largest share in global market What is the overall duration of the study period of this market? The study period of this market is from 2021-2030. Sources https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128641/ https://www.fda.gov/medical-devices/recently-approved-devices/gorer-excluderr-conformable-aaa-endoprosthesis-p200030 Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Market Segmentation 1.3.2 Geographic Scope Figure 02: Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.2.1.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure 05: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table 2: Risk Assessment Chapter 3. Executive Summary 3.1 Market: Post-Covid-19 Figure 06: Impact of Covid-19 on Market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Market, 2020–2028 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Market, 2020–2028 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Market, 2020–2028(USD Million) 3.1.4 Market Summary Figure 10: Abdominal Aortic Aneurysm (AAA) to Witness Highest CAGR in Market, By Type, During Forecast Period Figure 11: Hospitals Higher CAGR in Market for End-User Segment during Forecast Period Figure 12: North America to Account for Largest Share of Global Market In 2020 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 13: Market Segmentation Chapter 5. Industry Outlook 5.1 Global Endovascular Aneurysm Repair Market Snapshot 5.2 Global Market 5.2.1 Global Market, 2020 – 2028 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Global Market, by region, 2021 - 2030 (USD Million) 5.4 Type Segment Analysis 5.4.1 Global Market, by Type, 2021 - 2030 (USD Million) 5.5 End-User Segment Analysis 5.5.1 Global Market, By End-User, 2021 - 2030 (USD Million) 5.6 Value Chain Analysis 5.7 Market Variable Analysis 5.7.1 Market Drivers Analysis 5.7.2 Market Restraints Analysis 5.8 Business Environment Analysis Tool 5.8.1 Market PEST analysis 5.8.2 Market Porter’s analysis 5.9 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 14 Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 15 Market Drivers and Their Impact 6.2.2 Restraints Figure 16 Market Restraints and Their Impact 6.2.3 Opportunities Figure 17 Market Opportunities and Their Impact 6.2.4 Challenges Figure 18 Market Challenges and Their Impact 6.3 Impact of Covid-19 on Market 6.4 Value Chain Analysis Figure 19 Value Chain Analysis: Market 6.5 Ecosystem Figure 20 Market: Ecosystem Table 3 Market: Ecosystem Figure 21 Revenue Shift in Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Market in USA in Last 9 Years Figure 22 Top 12 Companies with Highest No. of Patents in Last 9 Years Figure 23 No of Patents Granted Per Year, 2019–2020 Table 5 List of Global Patents in Market 6.7 Trade Analysis Figure 24 Import Data for Abdominal Aortic Aneurysm, By Country, 2016–2020 (USD Thousand) Table 6 Import Data for Thoracic Aortic Aneurysm, By Country, 2016–2020 (USD Thousand) Figure 25 Import Data for Cerebral Aortic Aneurysm, By Country, 2016–2020 (USD Thousand) Table 7 Import Data for Others, By Country, 2016–2020 (USD Thousand) Figure 26 Export Data for Abdominal Aortic Aneurysm, By Country, 2016–2020 (USD Thousand) Table 8 Export Data for Thoracic Aortic Aneurysm, By Country, 2016–2020 (USD Thousand) Figure 27 Export Data for Cerebral Aortic Aneurysm, By Country, 2016–2020 (USD Thousand) Table 9 Export Data for Others, By Country, 2016–2020 (USD Thousand) 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 10 Market: Porter’s Five Forces Analysis, 2020 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Technology Analysis 6.11.1 Trends in Technology (2014-2020) 6.11.2 Trends in Technology (2021-2028) Table 11 Key Regulations: Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 12: Key Players market share Figure 28: Key players market share of companies 7.2 Manufacturers Endovascular Aneurysm Repair Manufacturing Sites, Area Served, Product Type 7.3 Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Market: Type Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2020-2028) Table 13 Markets, By Type, 2021–2028 (USD Million) Figure 29 Markets, By Type Figure 30 Abdominal Aortic Aneurysm (AAA) Segment to Register Highest CAGR in Market during Forecast Period 8.3 Abdominal Aortic Aneurysm 8.3.1 Abdominal Aortic Aneurysm market, 2021 - 2030 (USD Million) Figure 31: Abdominal Aortic Aneurysm market, 2021 - 2030 (USD Million) 8.4 Thoracic Aortic Aneurysm 8.4.1 Thoracic Aortic Aneurysm market, 2021 - 2030 (USD Million) Figure 32: Thoracic Aortic Aneurysm market, 2021 - 2030 (USD Million) 8.5 Cerebral Aortic Aneurysm 8.5.1 Cerebral Aortic Aneurysm market, 2021 - 2030 (USD Million) Figure 33: Cerebral Aortic Aneurysm market, 2021 - 2030 (USD Million) 8.6 Others 8.6.1 Others market, 2021 - 2030 (USD Million) Figure 34: Others market, 2021 - 2030 (USD Million) Chapter 9. Global Market: End-User Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2020-2028) Table 14: Market, By End-User, 2021–2028 (USD Million) Figure 35: Market, By End-User, 2021–2028 (USD Million) Figure 36: Hospitals Segment to Register Highest CAGR in Market during Forecast Period 9.3 Hospitals 9.3.1 Hospitals market, 2021 - 2030 (USD Million) Figure 37: Hospitals market, 2021 - 2030 (USD Million) 9.4 Clinics 9.4.1 Clinics market, 2021 - 2030 (USD Million) Figure 38: Clinics market, 2021 - 2030 (USD Million) 9.5 Ambulatory Surgical Centers 9.5.1 Ambulatory Surgical Centers market, 2021 - 2030 (USD Million) Figure 39: Ambulatory Surgical Centers market, 2021 - 2030 (USD Million) 9.7 Others 9.7.1 Others market, 2021 - 2030 (USD Million) Figure 40: Others market, 2021 - 2030 (USD Million) Chapter 10. Global Market: Regional Outlook 10.1 North America Figure 41: North America Market, By Revenue Forecast (2020-2028) 10.1.1 North America Market, by country, 2021 - 2030 (USD Million) Table 15: North America Market, by Country, 2020-2028 Figure 42: North America Market 10.1.2 North America Market, by Type, 2021 - 2030 (USD Million) Table16: North America Market, by Type, 2021 - 2030 (USD Million) Figure 43: North America Market, by Type, 2021 - 2030 (USD Million) 10.1.3 North America Market, by End-User, 2021 - 2030 (USD Million) Table 17: North America Market, by End-User, 2021 - 2030 (USD Million) Figure 44: North America Market, by End-User, 2021 - 2030 (USD Million) 10.1.4 U.S. 10.1.4.1 U.S. Market, by Type, 2021 - 2030 (USD Million) Figure 45: U.S. Market, by Type, 2021 - 2030 (USD Million) 10.1.4.2 U.S. Market, by End-User, 2021 - 2030 (USD Million) Figure 46: U.S. Market, by End-User, 2021 - 2030 (USD Million) 10.1.5 Canada 10.1.5.1 Canada Market, by Type, 2021 - 2030 (USD Million) Figure 47: Canada Market, by Type, 2021 - 2030 (USD Million) 10.1.5.2 Canada Market, by End-User, 2021 - 2030 (USD Million) Figure 48: Canada Market, by End-User, 2021 - 2030 (USD Million) Figure 49: Canada Market, by End-User, 2021 - 2030 (USD Million) Figure 50: Canada Market, by End-User, 2021 - 2030 (USD Million) 10.2 Europe Figure 51: Europe Market, By Revenue Forecast (2020-2028) 10.2.1 Europe Market, by country, 2021 - 2030 (USD Million) Table 18: Europe Market, by country, 2021 - 2030 (USD Million) Figure 52: Europe Market, by country, 2021 - 2030 (USD Million) 10.2.2 Europe Market, by Type, 2021 - 2030 (USD Million) Table 19: Europe Market, by Type, 2021 - 2030 (USD Million) Figure 53: Europe Market, by Type, 2021 - 2030 (USD Million) 10.2.3 Europe Market, by End-User, 2021 - 2030 (USD Million) Table 20: Europe Market, by End-User, 2021 - 2030 (USD Million) Figure 54: Europe Market, by End-User, 2021 - 2030 (USD Million) 10.2.4 U.K. 10.2.4.1 U.K. Market, by Type, 2021 - 2030 (USD Million) Figure 55: U.K. Market, by Type, 2021 - 2030 (USD Million) 10.2.4.2 U.K. Market, by End-User, 2021 - 2030 (USD Million) Figure 56: U.K. Market, by End-User, 2021 - 2030 (USD Million) 10.2.5 Germany 10.2.5.1 Germany Market, by Type, 2021 - 2030 (USD Million) Figure 57: Germany Market, by Type, 2021 - 2030 (USD Million) 10.2.5.2 Germany Market, by End-User, 2021 - 2030 (USD Million) Figure 58: Germany Market, by End-User, 2021 - 2030 (USD Million) 10.2.6 France 10.2.6.1 France Market, by Type, 2021 - 2030 (USD Million) Figure 59: France Market, by Type, 2021 - 2030 (USD Million) 10.2.6.2 France Market, by End-User, 2021 - 2030 (USD Million) Figure 60: France Market, by End-User, 2021 - 2030 (USD Million) 10.2.7 Rest of Europe 10.2.7.1 Rest of Europe Market, by Type, 2021 - 2030 (USD Million) Figure 61: Rest of Europe Market, by Type, 2021 - 2030 (USD Million) 10.2.7.2 Rest of Europe Market, by End-User, 2021 - 2030 (USD Million) Figure 62: Rest of Europe Market, by End-User, 2021 - 2030 (USD Million) 10.3 Asia Pacific Figure 63: Asia Pacific Market, By Revenue Forecast (2020-2028) 10.3.1 Asia Pacific Market, by country, 2021 - 2030 (USD Million) Table 21: Asia Pacific Market, by country, 2021 - 2030 (USD Million) Figure 64: Asia Pacific Market, by country, 2021 - 2030 (USD Million) 10.3.2 Asia Pacific Market, by Type, 2021 - 2030 (USD Million) Table 22: Asia Pacific Market, by Type, 2021 - 2030 (USD Million) Figure 65: Asia Pacific Market, by Type, 2021 - 2030 (USD Million) 10.3.3 Asia Pacific Market, by End-User, 2021 - 2030 (USD Million) Table 23: Asia Pacific Market, by End-User, 2021 - 2030 (USD Million) Figure 66: Asia Pacific Market, by End-User, 2021 - 2030 (USD Million) 10.3.4 China 10.3.4.1 China Market, by Type, 2021 - 2030 (USD Million) Figure 67: China Market, by Type, 2021 - 2030 (USD Million) 10.3.4.2 China Market, by End-User, 2021 - 2030 (USD Million) Figure 68: China Market, by End-User, 2021 - 2030 (USD Million) 10.3.5 India 10.3.5.1 India Market, by Type, 2021 - 2030 (USD Million) Figure 69: India Market, by Type, 2021 - 2030 (USD Million) 10.3.5.2 India Market, by End-User, 2021 - 2030 (USD Million) Figure 70: India Market, by End-User, 2021 - 2030 (USD Million) 10.3.6 Japan 10.3.6.1 Japan Market, by Type, 2021 - 2030 (USD Million) Figure 71: Japan Market, by Type, 2021 - 2030 (USD Million) 10.3.6.2 Japan Market, by End-User, 2021 - 2030 (USD Million) Figure 72: Japan Market, by End-User, 2021 - 2030 (USD Million) 10.3.7 South Korea 10.3.7.1 South Korea Market, by Type, 2021 - 2030 (USD Million) Figure 73: South Korea Market, by Type, 2021 - 2030 (USD Million) 10.3.7.2 South Korea Market, by End-User, 2021 - 2030 (USD Million) Figure 74: South Korea Market, by End-User, 2021 - 2030 (USD Million) 10.3.8 Rest of APAC 10.3.8.1 Rest of APAC Market, by Type, 2021 - 2030 (USD Million) Figure 75: Rest of APAC Market, by Type, 2021 - 2030 (USD Million) 10.3.8.2 Rest of APAC Market, by End-User, 2021 - 2030 (USD Million) Figure 76: Rest of APAC Market, by End-User, 2021 - 2030 (USD Million) 10.4 Latin America Figure 77: Latin America Market, By Revenue Forecast (2020-2028) 10.4.1 Latin America Market, by country, 2021 - 2030 (USD Million) Table 24: Latin America Market, by country, 2021 - 2030 (USD Million) Figure 78: Latin America Market, by country, 2021 - 2030 (USD Million) 10.4.2 Latin America Market, by Type, 2021 - 2030 (USD Million) Table 25: Latin America Market, by Type, 2021 - 2030 (USD Million) Figure 79: Latin America Market, by Type, 2021 - 2030 (USD Million) 10.4.3 Latin America Market, by End-User, 2021 - 2030 (USD Million) Table 26: Latin America Market, by End-User, 2021 - 2030 (USD Million) Figure 80: Latin America Market, by End-User, 2021 - 2030 (USD Million) 10.4.4 Brazil 10.4.4.1 Brazil Market, by Type, 2021 - 2030 (USD Million) Figure 81: Brazil Market, by Type, 2021 - 2030 (USD Million) 10.4.4.2 Brazil Market, by End-User, 2021 - 2030 (USD Million) Figure 82: Brazil Market, by End-User, 2021 - 2030 (USD Million) 10.4.5 Mexico 10.4.5.1 Mexico Market, by Type, 2021 - 2030 (USD Million) Figure 83: Mexico Market, by Type, 2021 - 2030 (USD Million) 10.4.5 2 Mexico Market, by End-User, 2021 - 2030 (USD Million) Figure 84: Mexico Market, by End-User, 2021 - 2030 (USD Million) 10.4.6 Rest of the Latin America 10.4.6.1 Rest of the Latin America Market, by Type, 2021 - 2030 (USD Million) Figure 85: Rest of the Latin America Market, by Type, 2021 - 2030 (USD Million) 10.4.6.2 Rest of the Latin America Market, by End-User, 2021 - 2030 (USD Million) Figure 86: Rest of the Latin America Market, by End-User, 2021 - 2030 (USD Million) 10.5 MEA Figure 87: MEA Market, By Revenue Forecast (2020-2028) 10.5.1 MEA Market, by Type, 2021 - 2030 (USD Million) Figure 88: MEA Market, by Type, 2021 - 2030 (USD Million) 10.5.2 MEA Market, by End-User, 2021 - 2030 (USD Million) Figure 89: MEA Market, by End-User, 2021 - 2030 (USD Million) Chapter 11. Competitive Landscape 11.1 Medtronic plc. 11.1.1 Company overview 11.1.2 Financial performance 11.1.3 Product Portfolio Analysis 11.1.4 Business Strategy & Recent Development 11.2 Cook Group Incorporated. 11.2.1 Company overview 11.2.2 Financial performance 11.2.3 Product Portfolio Analysis 11.2.4 Business Strategy & Recent Development 11.3 W.L. Gore & Associates Inc. 11.3.1 Company overview 11.3.2 Financial performance 11.3.3 Product Portfolio Analysis 11.3.4 Business Strategy & Recent Development 11.4 Bolton Medical Inc. 11.4.1 Company overview 11.4.2 Financial performance 11.4.3 Product Portfolio Analysis 11.4.4 Business Strategy & Recent Development 11.5 Gamida Cell Ltd. 11.5.1 Company overview 11.5.2 Financial performance 11.5.3 Product Portfolio Analysis 11.5.4 Business Strategy & Recent Development 11.6 JOTEC GmbH. 11.6.1 Company overview 11.6.2 Financial performance 11.6.3 Product Portfolio Analysis 11.6.4 Business Strategy & Recent Development 11.7 Getinge AB (Maquet). 11.7.1 Company overview 11.7.2 Financial performance 11.7.3 Product Portfolio Analysis 11.7.4 Business Strategy & Recent Development 11.8 Shanghai MicroPort Medical (Group) Co.Ltd. 11.8.1 Company overview 11.8.2 Financial performance 11.8.3 Product Portfolio Analysis 11.8.4 Business Strategy & Recent Development 11.9 Terumo Corporation. 11.9.1 Company overview 11.9.2 Financial performance 11.9.3 Product Portfolio Analysis 11.9.4 Business Strategy & Recent Development 11.10 Endologix Inc. 11.10.1 Company overview 11.10.2 Financial performance 11.10.3 Product Portfolio Analysis 11.10.4 Business Strategy & Recent Development 11.11 Lombard Medical Limited. 11.11.1 Company overview 11.11.2 Financial performance 11.11.3 Product Portfolio Analysis 11.11.4 Business Strategy & Recent Development 11.12 Cardinal Health. 11.12.1 Company overview 11.12.2 Financial performance 11.12.3 Product Portfolio Analysis 11.12.4 Business Strategy & Recent Development